Refrigeration at 28C maintains potency for 28 days post-mixing
Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
The parent molecule, Thymosin Beta-4, has undergone various legitimate Phase I and Phase II clinical trials with highly encouraging results
Iran J Pharm Res 11:481493 Wang S, McClements DJ, Lan Q et al (2025) Fabrication of composite hydrogels by sonication-assisted assembly of okara cellulose nanofibers and guar gum: unraveling structure, properties, and tofu quality enhancement
However, patients should be cautious if they are taking other skin-lightening agents or antioxidants, as there may be an additive effect that could potentially lead to skin irritation or hypersensitivity reactions
